2001•Practica Oto-Rhino-LaryngologicaOpen access

Electoroneuronography (ENoG); Preoperative Facial Nerve Assessment for Parotid Gland Tumors.

Katsura Kawata, Hideyuki Fukushima, Hajime Nakamura, Yoshihiro Tamura, Tetsuya Tamura, Shin‐ichi Kanemaru

Open full text 0 citations

Abstract

Parotid gland tumor are often associated with carcinomatous infiltration into facial nerves without overt manifestations of facial nerve palsy, which makes preoperative predictions of carcinomatous infiltration difficult. ENoG has been shown to be a useful approach to evaluate facial nerve degeneration. Here, we measured facial nerve function by performing ENoG preoperatively on patients with parotid gland tumors prior to investigate the usefulness of ENoG in preoperative examination of these tumors.Subjects: Twenty healthy individuals without any history of facial nerve palsy and 18 patients with parotid gland tumors (13 with benign tumors and 5 with malignant tumors) but no overt facial nerve palsy.Results: Mean ENoG values obtained for each groups were 103.5% (control), 82.2% (benign) and 48.1% (malignant). The mean ENoG values for the malignant group was significantly different compared to the other two groups (p<0.05). Differences in sizes or regions of tumors did not affect ENoG values significantly.Conclusion: ENoG was useful for the preoperative evaluation of facial nerve function. We suggest that a 50% reduction or more in ENoG values may predict the malignancy of tumor and a high risk for carcinomatous infiltration into facial nerves without any manifestations of facial nerve palsy.

Open-access reader

About this research paper

What this paper is about

Parotid gland tumor are often associated with carcinomatous infiltration into facial nerves without overt manifestations of facial nerve palsy, which makes preoperative predictions of carcinomatous infiltration difficult. ENoG has been shown to be a useful approach to evaluate facial nerve degeneration. Here, we measured facial nerve function by performing ENoG preoperatively on patients with parotid gland tumors prior to investigate the usefulness of ENoG in preoperative examination of these tumors.Subjects: Twenty healthy individuals without any history of facial nerve palsy and 18 patients with parotid gland tumors (13 with benign tumors and 5 with malignant tumors) but no overt facial nerve palsy.Results: Mean ENoG values obtained for each groups were 103.5% (control), 82.2% (benign) and 48.1% (malignant). The mean ENoG values for the malignant group was significantly different compared to the other two groups (p<0.05). Differences in sizes or regions of tumors did not affect ENoG values significantly.Conclusion: ENoG was useful for the preoperative evaluation of facial nerve function. We suggest that a 50% reduction or more in ENoG values may predict the malignancy of tumor and a high risk for carcinomatous infiltration into facial nerves without any manifestations of facial nerve palsy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Parotid gland tumor are often associated with carcinomatous infiltration into facial nerves without overt manifestations of facial nerve palsy, which makes preoperative predictions of carcinomatous infiltration difficult. ENoG has been shown to be a useful approach to evaluate facial nerve degeneration. Here, we measured facial nerve function by performing ENoG preoperatively on patients with parotid gland tumors prior to investigate the usefulness of ENoG in preoperative examination of these tumors.Subjects: Twenty healthy individuals without any history of facial nerve palsy and 18 patients with parotid gland tumors (13 with benign tumors and 5 with malignant tumors) but no overt facial nerve palsy.Results: Mean ENoG values obtained for each groups were 103.5% (control), 82.2% (benign) and 48.1% (malignant). The mean ENoG values for the malignant group was significantly different compared to the other two groups (p<0.05). Differences in sizes or regions of tumors did not affect ENoG values significantly.Conclusion: ENoG was useful for the preoperative evaluation of facial nerve function. We suggest that a 50% reduction or more in ENoG values may predict the malignancy of tumor and a high risk for carcinomatous infiltration into facial nerves without any manifestations of facial nerve palsy.

Key concepts: Facial nerve, Electroneuronography, Medicine, Palsy, Parotid gland, Malignancy, Facial paralysis, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Electoroneuronography (ENoG); Preoperative Facial Nerve Assessment for Parotid Gland Tumors. — Research Paper | ScholarLens